NO20022156L - Kinolin- og naftyridinkarboksylsyre antibakterielle midler - Google Patents

Kinolin- og naftyridinkarboksylsyre antibakterielle midler

Info

Publication number
NO20022156L
NO20022156L NO20022156A NO20022156A NO20022156L NO 20022156 L NO20022156 L NO 20022156L NO 20022156 A NO20022156 A NO 20022156A NO 20022156 A NO20022156 A NO 20022156A NO 20022156 L NO20022156 L NO 20022156L
Authority
NO
Norway
Prior art keywords
antibacterial agents
quinoline
acid antibacterial
naphthyridinecarboxylic acid
hydrogen
Prior art date
Application number
NO20022156A
Other languages
English (en)
Other versions
NO20022156D0 (no
Inventor
Steven W Elmore
Curt S Cooper
Colleen C Schultz
Douglas K Hutchinson
Pamela L Donner
Brian E Green
David D Anderson
Qinghua Xie
Jurgen Dinges
Linda M Lynch
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of NO20022156D0 publication Critical patent/NO20022156D0/no
Publication of NO20022156L publication Critical patent/NO20022156L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Forbindelser med formel (I) (D, eller farmasøytisk akseptable salter eller prodroger derav, hvori A1 er nitrogen eller (II), hvori W er valgt fra grup- pen bestående av (i) hydrogen og (2) eventuelt substituert alkyl; A2 er valgt fra gruppen bestående av (1) -S-, (2) - O- og (3) -N(R7)-, hvori R7 er hydrogen eller Ci-C6 alkyl; og R5 og R6 sammen er en karbocyklisk eller en hetero- cyklisk ring, er nyttige som antibakterielle midler.
NO20022156A 1999-11-05 2002-05-06 Kinolin- og naftyridinkarboksylsyre antibakterielle midler NO20022156L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43529799A 1999-11-05 1999-11-05
US70533200A 2000-11-03 2000-11-03
PCT/US2000/030551 WO2001032655A2 (en) 1999-11-05 2000-11-06 Quinoline and naphthyridine carboxylic acid antibacterials

Publications (2)

Publication Number Publication Date
NO20022156D0 NO20022156D0 (no) 2002-05-06
NO20022156L true NO20022156L (no) 2002-07-04

Family

ID=27030507

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022156A NO20022156L (no) 1999-11-05 2002-05-06 Kinolin- og naftyridinkarboksylsyre antibakterielle midler

Country Status (12)

Country Link
EP (1) EP1226146A2 (no)
JP (1) JP2003524633A (no)
AR (1) AR030537A1 (no)
AU (1) AU1468901A (no)
BG (1) BG106679A (no)
BR (1) BR0010728A (no)
CZ (1) CZ20021531A3 (no)
HK (1) HK1047287A1 (no)
IL (1) IL148738A0 (no)
MX (1) MXPA02004474A (no)
NO (1) NO20022156L (no)
WO (1) WO2001032655A2 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002018345A1 (en) * 2000-08-29 2002-03-07 Chiron Corporation Quinoline antibacterial compounds and methods of use thereof
WO2002088298A1 (en) 2001-04-27 2002-11-07 The Procter & Gamble Company Compounds, compositions, and methods for controlling biofilms
US8163769B2 (en) 2002-03-12 2012-04-24 Abbott Laboratories Antibacterial compounds
MXPA05009688A (es) * 2003-03-12 2005-12-05 Abbott Lab Derivados de naftiridina como agentes antibacterianos.
EP1829869A1 (en) * 2006-03-02 2007-09-05 Laboratorios Del Dr. Esteve, S.A. 4,5,6,7-Tetrahydrobenzo[b]thiophene derivatives and their use as sigma receptor ligands
US20080139574A1 (en) 2006-11-30 2008-06-12 Cadila Healthcare Limited Novel quinoline derivatives
TWI498115B (zh) * 2007-12-27 2015-09-01 Daiichi Sankyo Co Ltd 咪唑羰基化合物
SG10201510665WA (en) 2009-12-04 2016-01-28 Sunovion Pharmaceuticals Inc Multicycle Compounds And Pharmaceutical Compositions Useful For The Treatment Of Neurological Disorders
MA45795A (fr) 2016-07-29 2019-06-05 Sunovion Pharmaceuticals Inc Composés et compositions, et utilisations associées
IL264446B1 (en) 2016-07-29 2024-05-01 Pgi Drug Discovery Llc Compounds and compositions and their use
IL268694B2 (en) 2017-02-16 2023-10-01 Sunovion Pharmaceuticals Inc Treatment of schizophrenia
BR112020001433A2 (pt) 2017-08-02 2020-07-28 Sunovion Pharmaceuticals Inc. compostos de isocromano e usos dos mesmos
KR20200122345A (ko) 2018-02-16 2020-10-27 선오비온 파마슈티컬스 인코포레이티드 염, 결정 형태 및 이들의 제조 방법
CA3130849A1 (en) 2019-03-14 2020-09-17 Sunovion Pharmaceuticals Inc. Salts of a isochromanyl compound and crystalline forms, processes for preparing, therapeutic uses, and pharmaceutical compositions thereof
KR20230003503A (ko) 2020-04-14 2023-01-06 선오비온 파마슈티컬스 인코포레이티드 신경학적 및 정신의학적 장애의 치료를 위한 (S)-(4,5-디히드로-7H-티에노[2,3-c]피란-7-일)-N-메틸메탄아민

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4665079A (en) * 1984-02-17 1987-05-12 Warner-Lambert Company Antibacterial agents

Also Published As

Publication number Publication date
MXPA02004474A (es) 2002-11-07
BR0010728A (pt) 2004-02-17
AR030537A1 (es) 2003-08-27
JP2003524633A (ja) 2003-08-19
EP1226146A2 (en) 2002-07-31
CZ20021531A3 (cs) 2002-09-11
AU1468901A (en) 2001-05-14
NO20022156D0 (no) 2002-05-06
BG106679A (bg) 2003-01-31
WO2001032655A2 (en) 2001-05-10
WO2001032655A3 (en) 2002-01-24
HK1047287A1 (zh) 2003-02-14
IL148738A0 (en) 2002-09-12

Similar Documents

Publication Publication Date Title
NO20022156L (no) Kinolin- og naftyridinkarboksylsyre antibakterielle midler
KR20050085991A (en) Compounds exhibiting thrombopoietin receptor agonism
AR029216A1 (es) Compuestos inhibidores no peptidicos de la union celular dependiente de vla-4 utiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias; composicion farmaceutica y procedimiento de tratamiento
BG106073A (en) Quinoline derivatives as inhibitors of mek enzymes
CO5280078A1 (es) Compuestos
MXPA05003193A (es) Compuesto de adenina novedoso y uso del mismo.
NO20031561L (no) Kjemiske forbindelser
HRP20070510T3 (en) Benzimidazole derivative and its use as a ii receptor antagonist
NO20051047L (no) Fremgangsmate og mellomprodukter for fremstilling av tienopyrrolderivater
TNSN03045A1 (en) QUINAZOLINES AS MMP-13 INHIBITORS
NO20015447L (no) Kinolinderivater som inhibitorer av MEK enzymer
EP1813270A4 (en) PROTEIN INHIBITORS OF THE HSP90 FAMILY
AU2629795A (en) Aniline derivative having the effect of inhibiting nitrogen monoxide synthase
DE60042013D1 (de) Nitroxyderivate mit entzündungshemmender, analgetischer und antithrombotischer wirkung
ATE398627T1 (de) C-2-modifizierte erythromycinderivate
HUT62264A (en) Process for producing amidino compounds and pharmaceutical compositions comprising same as active ingredient
MY140325A (en) Indanyl-piperazine derivatives, process for their preparation and pharmaceutical compositions containing them
MY140749A (en) Novel piperidine compound
CA2120028A1 (en) Indol Derivatives for the Treatment of Migrane
HUP0303186A2 (hu) 4-Amino-benzopirán-származékok
HRP20070030T3 (en) Derivatives of benzothiazine and benzothiadiazine, procedure for their preparation and pharmaceutical compositions containing them
EP1655291A4 (en) COMPOUNDS WITH THROMBOPOIETIN RECEPTOR AGONISM
DK1204658T3 (da) Benzofurylpiperazin-serotoninagonister
HUP0004704A2 (hu) Dihidrofuro[3,4-b]kinolin-1-on-származékok, eljárás ezek előállítására és ezeket tartalmazó gyógyászati készítmények
EP1134219A4 (en) AMINOMETHYLPYRROLIDINE DERIVATIVES SUBSTITUTED BY CYCLOALKYLES

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application